Selective laser trabeculoplasty: mechanisms of action and predictors of efficacy

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

This review considered selective laser trabeculoplasty in comparison with other methods for therapeutic and surgical treatment of primary open-angle glaucoma and ocular hypertension, including argon laser trabeculoplasty. In this paper, we reviewed current knowledge on the mechanisms of action of selective laser trabeculoplasty, predictors of intraocular pressure-lowering effect, repeatability, and safety of this procedure.

Full Text

Restricted Access

About the authors

Alexey N. Kulikov

S.M. Kirov Military Medical Academy

Email: alexey.kulikov@mail.ru

MD, PhD, DSc, Assistant Professor, Head of the Ophthalmology Department

Russian Federation, Saint Petersburg

Alina A. Kazak

S.M. Kirov Military Medical Academy

Email: alinakazak96@gmail.com

Medical student

Russian Federation, Saint Petersburg

Dmitrii S. Maltsev

S.M. Kirov Military Medical Academy

Author for correspondence.
Email: glaz.med@yandex.ru
ORCID iD: 0000-0001-6598-3982

MD, PhD, Head of Medical Retina Division of Ophthalmology Department

Russian Federation, Saint Petersburg

References

  1. Старостина А.В. Хирургическая профилактика и устранение блокады зоны операции корнем радужки при непроникающей глубокой склерэктомии у пациентов с первичной открытоугольной глаукомой: Автореф. дис. … канд. мед. наук. – М., 2017. – 26 с. [Starostina AV. Khirurgicheskaya profilaktika i ustraneniye blokady zony operatsii kornem raduzhki pri nepronikayushchey glubokoy skler·ektomii u patsiyentov s pervichnoy otkrytougol’noy glaukomoy. [dissertation abstract] Moscow; 2017. 26 р. (In Russ.)]. Доступно по: https://search.rsl.ru/ru/record/01008711543. Ссылка активна на 14.02.2020.
  2. Шараф В.М., Сипливый В.И. Эпидемиологические особенности клинического течения глаукомы в зависимости от социальных, экономических, этнических и географических факторов // Национальный журнал Глаукома. – 2014. – № 1. – С. 68–76. [Charaf WM, Siplivy VI. Epidemiological aspects of glaucoma clinical progression, depending on social, economic, ethnic and geographic factors. National Journal Glaucoma. 2014;(1):68-76. (In Russ.)]
  3. Conlon R, Saheb H, Ahmed II. Glaucoma treatment trends: a review. Can J Ophthalmol. 2017;52(1):114-124. https://doi.org/10.1016/j.jcjo.2016.07.013.
  4. Burr J, Azuara-Blanco A, Avenell A, Tuulonen A. Medical versus surgical interventions for open angle glaucoma. Cochrane Database Syst Rev. 2012;12(9): CD004399. https://doi.org/10.1002/14651858.CD004399.pub3.
  5. Светозарский С.Н., Масленникова Ю.А., Аникеева М.В. Современные технологии хирургического лечения открытоугольной глаукомы // Современные технологии в медицине. – 2014. – Т. 6. – № 1. – С. 102–109. [Svetozarskiy SN, Maslennikova YuA, Anikeyeva MV. Sovremennyye tekhnologii khirurgicheskogo lecheniya otkrytougol’noy glaukomy. Sovremennye tehnologii v medicine. 2014;6(1):102-109. (In Russ.)]
  6. Егоров Е.А., Астахов Ю.С., Ставицкая Т.В. Общие принципы медикаментозного лечения заболеваний глаз // Клиническая офтальмология. – 2004. – Т. 5. – № 1. – C. 2–4. [Egorov EA, Astakhov YuS, Stavitskaya TV. Obshchiye printsipy medikamentoznogo lecheniya zabolevaniy glaz. Klinicheskaja oftal’mologija. 2004;5(1):2-4. (In Russ.)]
  7. Sayner R, Carpenter DM, Robin AL, et al. How glaucoma patient characteristics, self-efficacy and patient-provider communication are associated with eye drop technique. Int J Pharm Pract. 2016;24(2):78-85. https://doi.org/10.1111/ijpp.12215.
  8. Baudouin C. Detrimental effect of preservatives in eyedrops: implications for the treatment of glaucoma. Acta Ophthalmol. 2008;86(7):716-726. https://doi.org/10.1111/j.1755-3768.2008. 01250.x.
  9. Lee SM, Lee JE, Kim SI, et al. Effect of topical glaucoma medication on tear lipid layer thickness in patients with unilateral glaucoma. Indian J Ophthalmol. 2019;67(8):1297-1302. https://doi.org/10.4103/ijo.IJO_2100_18.
  10. Arita R, Itoh K, Maeda S, et al. Comparison of the long-term effects of various topical antiglaucoma medications on meibomian glands. Cornea. 2012;31(11):1229-1234. https://doi.org/10.1097/ICO.0b013e31823f8e7d.
  11. Heijl A, Leske MC, Bengtsson B, et al. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002;120(10):1268-1279. https://doi.org/10.1001/archopht.120.10.1268.
  12. Litoriya A, Tiwari US, Pathak R. Effect of various topical anti glaucoma drugs on cardiopulmonary system. A prospective study. Rom J Ophthalmol. 2019;63(2):142-145. https://doi.org/10.22336/rjo.2019.21.
  13. Garg A, Gazzard G. Selective laser trabeculoplasty: past, present, and future. Nature Research. Eye. 2018;32(5):863-876. https://doi.org/10.1038/eye.2017.273.
  14. Worthen DM, Wickham MG. Argon laser trabeculotomy: long-term follow-up. Ophthalmology. 1979;86(3):495-503. https://doi.org/10.1016/s0161-6420(79)35492-6.
  15. Krasnov MM. Laser puncture of anterior chamber angle in glaucoma. Am J Ophthalmol. 1973;75(4):674-678. https://doi.org/10.1016/0002-9394(73)90819-2.
  16. Wise JB, Witter SL. Argon laser therapy for open-angle glaucoma: A pilot study. Arch Ophthalmol. 1979;97(2):319-322. https://doi.org/10.1001/archopht.1979.01020010165017.
  17. Brubaker RF, Liesegang TJ. Effect of trabecular photocoagulation on the aqueous humor dynamics of the human eye. Am J Ophthalmol. 1983;96(2):139-147. https://doi.org/10.1016/s0002-9394(14)77780-3.
  18. Ekici F, Waisbourd M, Katz LJ. Current and future of laser therapy in the management of glaucom. Open Ophthalmology J. 2016;10: 56-67. https://doi.org/10.2174/1874364101610010056.
  19. Bradley JM, AnderssohnAM, Colvis CM, et al. Mediation of Laser Trabeculoplasty-Induced Matrix Metalloproteinase Expression by IL-1β and TNFα. Invest Ophthalmol Vis Sci. 2000;41(2):422-430. https://doi.org/10.1016/S0008-4182(00)80049-6.
  20. Ruddat MS, Alexander JR, Samples JR, et al. Early changes in trabecular metalloproteinase mRNA levels in response to laser trabeculoplasty are induced by media borne factors. ARVO Abstract. Invest Ophthalmol Vis Sd (Supplement). 1989;30:280.
  21. Hutnik C, Crichton A, Ford B, et al. Selective Laser trabeculoplasty versus argon laser trabeculoplasty in glaucoma patients treated previously with 360° selective laser trabeculoplasty. Ophthalmology. 2019:126(2):223-232. https://doi.org/10.1016/j.ophtha.2018.09.037.
  22. Latina MA, Park C. Selective targeting of trabecular meshwork cells: In vitro studies of pulsed and CW laser interactions. Exp Eye Res. 1995;60(4):359-371 https://doi.org/10.1016/s0014-4835(05)80093-4.
  23. Anderson RR, Parrish J. Selective photothermolysis: precise microsurgery by selective absorption of the pulsed radiation. Science. 1983;220(4596):524-526. https://doi.org/10.1126/science.6836297.
  24. Izzotti A, Longobardi M, Cartiglia C, et al. Trabecular meshwork gene expression after selective laser trabeculoplasty. PLoS One. 2011;6(7): e20110. https://doi.org/10.1371/journal.pone.0020110.
  25. Kramer TR, Noecker RJ. Comparison of the morphologic changes after selective laser trabeculoplasty and argon laser trabeculoplasty in human eye bank eyes. Ophthalmology. 2001;108(4):773-779. https://doi.org/10.1016/s0161-6420(00)00660-6.
  26. Soo Hoo JR, Seibold LK, Ammar DA, et al. Ultrastructural changes in human trabecular meshwork tissue after laser trabeculoplasty. J Ophthalmol. 2015;2015:476138. https://doi.org/10. 1155/2015/476138.
  27. Alvarado JA, Alvarado RG, Franse-Carman R, et al. A new insight into the cellular regulation of aqueous outflow: how trabecular meshwork endothelial cells drive a mechanism that regulates the permeability of Schlemm’s canal endothelial cells. Br J Ophthalmol. 2005;89(11):1500-1505. https://doi.org/10.1136/bjo.2005. 081307.
  28. Lee JY, Kagan DB, Roumeliotis G, et al. Secretion of MMP-3 by co-cultured pigmented and non-pigmented human trabecular meshwork cells following selective laser trabeculoplasty. Clin Exp Ophthalmol. 2016;44(1):33-42. https://doi.org/10.1111/ceo. 12591.
  29. Alvarado JA, Katz LJ, Trivedi S, et al. Monocyte modulation of aqueous outflow and recruitment to the trabecular meshwork following selective laser trabeculoplasty. Arch Ophthalmol. 2010;128(6):731-737. https://doi.org/10.1001/archophthalmol. 2010.85.
  30. McIlraith I, Strasfeld M, Colev G, Hutnik CM. Selective laser trabeculoplasty as initial and adjunctive treatment for open-angle glaucoma. J Glaucoma. 2006;15(2):124-130. https://doi.org/10.1097/00061198-200604000-00009.
  31. Gulati V, Fan S, Gardner BJ, et al. Mechanism of action of selective laser trabeculoplasty and predictors of response. Invest Ophthalmol Vis Sc. 2017;58(3):1462-1468. https://doi.org/10.1167/iovs.16-20710.
  32. McAlinden С. Selective laser trabeculoplasty (SLT) vs other treatment modalities for glaucoma: systematic review. Eye. 2014;28(3):249-258. https://doi.org/10.1038/eye.2013.267.
  33. Gazzard G, Konstantakopoulou E, Garway-Heath D, et al.; LiGHT Trial Study Group. Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial. Lancet. 2019;393(10180):1505-1516. https://doi.org/10.1016/S0140-6736(18)32213-X.
  34. Балалин С.В., Фокин В.П. Медикаментозное лечение первичной открытоугольной глаукомы. Индивидуальный подход // Клиническая офтальмология. – 2019. – Т. 19. – № 1. – С. 43–48. [Balalin SV, Fokin VP. Medikamentoznoye lecheniye pervichnoy otkrytougol’noy glaukomy. Individual’nyy podkhod. Klinicheskaja oftal’mologija. 2019;19(1):43-48. (In Russ.)]
  35. Shibata M, Sugiyama T, Ishida O, et al. Clinical results of selective laser trabeculoplasty in open-angle glaucoma in Japanese eyes: comparison of 180 degree with 360 degree SLT. J Glaucoma. 2012;21(1):17-21. https://doi.org/10.1097/IJG.0b013e3181fc8020.
  36. Курышева Н.И., Лепешкина Л.В., Шаталова Е.О. Предикторы неудачи селективной лазерной трабекулопластики при первичной закрытоугольной и открытоугольной глаукоме в отдаленном периоде // Российский офтальмологический журнал. – 2019. – Т. 12. – № 2. – С. 32–38. [Kurysheva NI, Lepeshkina LV, Shatalova EO. Success predictors of selective laser trabeculoplasty in primary angle-closure glaucoma: a long-term follow-up. Russian ophthalmological journal. 2019;12(2):32-38. (In Russ.)]
  37. Chun M, Gracitelli C, Lopes FS, et al. Selective laser trabeculoplasty for early glaucoma: analysis of success predictors and adjusted laser outcomes based on the untreated fellow eye. BMC Ophthalmol. 2016;16(1):206. https://doi.org/10.1186/s12886-016-0385-z.
  38. Gong JL, Al Wesabi SA, Zhao Y, Zhang H. Positive correlation between blood reflux in Schlemm’s canal and the decrease of intraocular pressure after selective laser trabeculoplasty in primary open-angle glaucoma. Exp Ther Med. 2018;15(6):5065-5069. https://doi.org/10.3892/etm.2018.6051.
  39. Grieshaber MC. Ab externo schlemm’s canal surgery: viscocanalostomy and canaloplasty. Dev Ophthalmol. 2012;50:109-124. https://doi.org/10.1159/000334793.
  40. Garg A, Vickerstaff V, Nathwani N, et al. Laser in Glaucoma and Ocular Hypertension Trial Study Group. Primary selective laser trabeculoplasty for open-angle glaucoma and ocular hypertension: clinical outcomes, predictors of success, and safety from the laser in glaucoma and ocular hypertension trial. Ophthalmology. 2019;126(9): 1238-1248. https://doi.org/10.1016/j.ophtha.2019.04.012.
  41. Realini T, Shillingford-Ricketts H, Burt D, Balasubramani GK. West Indies Glaucoma Laser Study (WIGLS): 1. 12-Month efficacy of selective laser trabeculoplasty in afro-caribbeans with glaucoma. Am J Ophthalmol. 2017;184:28-33. https://doi.org/10.1016/j.ajo.2017.09.022.
  42. Ayala M, Chen E. Long-term outcomes of selective laser trabeculoplasty (SLT) treatment. Open Ophthalmol. J. 2011;5:32-34. https://doi.org/10.2174/1874364101105010032.
  43. Yilmaz SG, Palamar M, Yusifov E, et al. Effects of primary selective laser trabeculoplasty on anterior segment parameters. Int J Ophthalmology. 2015;8(5):954-959. https://doi.org/10.3980/j.issn. 2222-3959.2015.05.18.
  44. ASCRS Eyeworld. Ahmed IK, Angelucci D. Best Paper of Session. Individual patient factors influence SLT success. [Accessed 2014 May 4] Available from: http://www.eyeworld.org/article.php?sid=2685.
  45. Lee JW, Liu CC, Chan J, et al. Predictors of success in selective laser trabeculoplasty for primary open angle glaucoma in Chinese. Clin Ophthalmol. 2014;8:1787-1791. https://doi.org/10.2147/OPTH.S69166.
  46. Resta V, Novelli E, Vozzi G, et al. Acute retinal ganglion cell injury caused by intraocular pressure spikes is mediated by endogenous extracellular ATP. Eur J Neurosci. 2007;25(9):2741-2754. https://doi.org/10.1111/j.1460-9568.2007.05528.x.
  47. Hirneiß C, Sekura K, Brandlhuber Resta V, et al. Corneal biomechanics predict the outcome of selective laser trabeculoplasty in medically uncontrolled glaucoma. Graefes Arch Clin Exp Ophthalmol. 2013;251(10):2383-2388.
  48. Marcelo A, Chen E. Predictive factors of success in selective laser trabeculoplasty (SLT) treatment. Clin Ophthalmol. 2011;5:573-576. https://doi.org/10.2147/OPTH.S19873.
  49. Lee JW, Wong MO, Liu CC, Lai JS. Optimal selective laser trabeculoplasty energy for maximal intraocular pressure reduction in open-angle glaucoma. J Glaucoma. 2015;24(5):e128-e131. https://doi.org/10.1097/IJG.0000000000000215.
  50. Habib L, Lin J, Berezina T. Selective laser trabeculoplasty: does energy dosage predict response? Oman J Ophthalmol. 2013;6(2): 92-95. https://doi.org/10.4103/0974-620X.116635.
  51. Tang M, Fu Y, Fu MS. The efficacy of low-energy selective laser trabeculoplasty. Ophthalmic Surg Lasers Imaging. 2011;42(1):59-63. https://doi.org/10.3928/15428877-20101124-07.
  52. Guzey M, Vura H, Satici A, et al. Increase of free oxygen radicals in aqueous humour induced by selective Nd: YAG laser trabeculoplasty in the rabbit. Eur J Ophthalmol. 2001;11(1):47-52.
  53. Leahy KE, Madigan MC, Sarris А, et al. Investigation of corneal endothelial changes post selective laser trabeculoplasty. Clin Exp Ophthalmol. 2018;46(7):730-737. https://doi.org/10.1111/ceo.13172.
  54. Lee JW, Chan JC, Chang RT, et al. Corneal changes after a single session of selective laser trabeculoplasty for open-angle glaucoma. Eye (Lond). 2014;28(1):47-52. https://doi.org/10.1038/eye.2013.231.
  55. Latina MA, Vikas G. Selective laser trabeculoplasty: stimulating the meshwork to mend its way. Int Ophthalmol Clin. 2004; 44(1):93-103. https://doi.org/10.1097/00004397-200404410- 00011.
  56. Ayala M, Landau Högbeck I, Chen E. Inflammation assessment after selective laser trabeculoplasty (SLT) treatment. Acta Ophthalmol. 2011;89(4):306-309. https://doi.org/10.1111/j.1755-3768.2010.02029.x.
  57. De Keyser M, De Belder M, De Groot V. Randomized prospective study of the use of anti-inflammatory drops after selective laser trabeculoplasty. J Glaucoma. 2017;26(2):22-29. https://doi.org/10.1097/IJG.0000000000000522.
  58. Selective Laser Trabeculoplasty in Controlled Uveitis with Steroid-Induced Glaucoma. Ophthalmology. 2016 Dec;123(12): 2630-2632. doi: 10.1016/j.ophtha.2016.07.027.
  59. Khouri AS, Lin J, Berezina TL, et al. Repeat selective laser trabeculoplasty can be effective in eyes with initial modest response. Middle East Afr J Ophthalmol. 2014;21(3):205-209. https://doi.org/10.4103/0974-9233.134668.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2020 Kulikov A.N., Kazak A.A., Maltsev D.S.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77-65574 от 04 мая 2016 г.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies